In the first part of this paper (Willcox, 1977 ) the incidence of those sexually transmitted diseases that usually present with genital discharge-namely gonorrhoea, candidosis, trichomoniasis, and nonspecific genital infection-was discussed and the treatments and needs for the future were reviewed. 
Introduction
In the first part of this paper (Willcox, 1977 ) the incidence of those sexually transmitted diseases that usually present with genital discharge-namely gonorrhoea, candidosis, trichomoniasis, and nonspecific genital infection-was discussed and the treatments and needs for the future were reviewed.
This part is concerned with the less common conditions that usually present with ulcers or swellings on the genital mucous membranes or skin. In order to show the prevalence of these conditions the number of cases seen in venereal disease clinics of England and Wales in 1974 are compared with the number of cases of gonorrhoea, and also of primary and secondary syphilis. increases in many countries, and it presents a smaller numerical problem than gonorrhoea. In England and Wales in 1974 reported cases of syphilis of all forms was only 7 % in men and 4% in women compared with gonorrhoea, while for primary and secondary syphilis the figures were only 4% and 1 % respectively (Fig. 1 These schedules have not been changed during the past decade except in the case of early congenital syphilis in which the inability of a single dose of benzathine penicillin to enter the cerebrospinal fluid has prompted much higher total doses of shorter acting penicillins to be recommended (Table 2) . Generally the amounts of penicillin given for the early infection tend to be greater in Europe. For example, in only a few centres is a single injection of benzathine penicillin prescribed, the daily dose of procaine penicillin is usually in the region of 900 000 to 1 2 megaunits and the number of twiceweekly injections of PAM after the initial epidemiological dose of 2-4 megaunits may be six or more.
Pharmaceutical difficulties
The treatment of syphilis is becoming increasingly more difficult largely because the pharmaceutical industry is failing to supply the necessary products, presumably as a reaction to market forces.
Crystalline penicillin G, although freely available, has to be given several times a day and is therefore disliked for inpatient treatment of syphilis and unsuitable for outpatients. Aqueous procaine penicillin, which is particularly suitable for inpatients, is becoming difficult to obtain. In the United Kingdom the only product available is imported from Holland; it can only be purchased in large quantities so it is therefore in practice available only to hospitals. Furthermore, unlike some preparations previously on the market, it has to be suspended before use. As with gonorrhoea the situation has markedly worsened during the past decade. In 1966 there were six products of procaine penicillin available in Britain. Today there is one imported product, Table 3 . The preferred treatment for these disorders is by means of sulphonamides or antibiotics given over varying periods of time for an average of two weeks, Table 4 ( Rein and Chapel, 1975; Willcox, 1975a) . Sulphonamides, with or without trimethoprim, are suitable for chancroid (soft sore) and lymphogranuloma venereum; streptomycin is suitable for soft sore and granuloma inguinale. Both tetracycline and chloramphenicol are effective in all three diseases but the latter is used only as a back-up drug because of haemopoietic toxicity.
In the treatment of chancroid there is resistance to tetracycline in parts of the Far East. Other drugs (for example, clindamycin, metronidazole, or penicillin) may also be required in the case of lesions superinfected with anaerobic organisms.
Needs for the future As these disorders are few numerically, the treatment of other sexually transmitted diseases should be given priority.
Parasitic diseases SCABIES Prevalence
In clinics in the United Kingdom scabies is approximately only 6 % as common in men and 2 % in women as gonorrhoea (Fig.3) but it is 1 6 times and twice respectively more common than primary and secondary syphilis. (Table 5) .
Needs for the future Treatments for scabies should be effective, free from adverse side effects (for example induction of dermatitis), and cosmetically and otherwise acceptable. The above treatments, if not perfect, are reasonable in these respects.
PEDICULOSIS PUBIS Prevalence
This condition is 10 % as common in men as gonorrhoea and 7 % as common in women. It is 2-6 and 5 3 times, respectively, more common than primary and secondary syphilis (Fig. 3) .
Treatment
Two at least of the substances used for the treatment of scabies (benzyl benzoate and gamma-benzene hexachloride) are also prescribed for pediculosis, for which five substances are available-that is, the above plus carbaryl, dicophane, and malathionalthough carbaryl is supplied as a shampoo purely for the treatment of head lice. Malathion and gamma-benzene hexachloride can be obtained in the form of shampoos.
Gamma-benzene hexachloride is available as a cream or lotion from two manufacturers: one recommends two treatments separated by seven days and the other recommends a single treatment (Table 6 ). (Fig. 4) (Oriel, 1976) , but there are few reports on its use in genital warts. The substance 5-fluorouracil was used for external and intrameatal warts and had best reported results on external warts with thrice daily applications (see Willcox, 1976 (Nel and Fourie, 1973) , but some (for example, Oriel, 1976) , question the wisdom of administering possible oncogenic material.
Needs for the future There is a need for a better locally administered substance that will destroy warts but leave normal tissue, and which is non-toxic and safe to give in pregnancy.
As warts tend to proliferate in pregnancy and particularly florid examples are found in Hodgkin's disease, as in both conditions there is depressed cell-mediated immunity, immunological approaches aimed at increasing such immunity deserve investigation.
MOLLUSCUM CONTAGIOSUM Prevalence
This condition is the least common of these three virus disorders-rates are only approximately one-hundredth of that for gonorrhoea in both sexes (Fig. 5) . Indeed in clinics of the United Kingdom primary and secondary syphilis in men is three times and in women 1 3 times more common than molluscum contagiosum. 
Treatment
Most of the destructive methods used locally for condylomata acuminata are also employed for molluscum contagiosum, but often with less success. However, the use of a finely sharpened wooden 'orange stick' dipped in liquid phenol and rotated under pressure in the centre of each umbilicated papule has proved useful.
HERPES GENITALIS Prevalence
This condition is approximately 8-9% as common in British clinics as gonorrhoea in both sexes and less than one-third as common as venereal warts, but in view of its potential dangerous complications in the adult and to the newborn child, it is regarded much more seriously than many of the others (Fig. 5: Willcox, 1975b) . It is 2-5 times more common than primary and secondary syphilis in men and 6 8 times in women.
Treatment
Local treatment The available treatment for herpes genitalis leaves much to be desired. Many antiseptic or astringent lotions and chemical or antibiotic creams have been used, some of which are listed in Table 8 (Young, 1972; Amstey, 1975; Morton, 1975; Juel Jensen, 1976; Nahmias et al., 1976) . In general these alleviate local discomfort and remove secondary infection if present. One of the three, rifampicin, is reported as having some viral action. Of chemotherapeutic measures co-trimoxazole has been considered clinically to be helpful (Laird and Roy, 1975) as have also griseofulvin (Sehgal, 1974) and metronidazole (Morton, 1975) . The effects of these on the herpes virus are at best only marginal.
Of anti-viral substances IDU is too toxic to be given systemically but other pyrimidine analoguescytosine arabinoside and adenosine arabinosidehave been used. Until now-for reasons of toxicity, the need to hospitalise for intravenous injections, and expense-these have been used almost exclusively on severe complicated cases-for example, encephalitis. Adenosine arabinoside is said to be effective against severe chicken pox and zoster (Juel Jensen, 1976) .
Immunological methods include those that stimulate cell-mediated immunity by the use of R. R. Willcox BCG vaccine (Amstey, 1975) , stimulate interferon production by means of inactivated influenza virus, or by synthetic double-stranded RNA (Amstey, 1975) . Experiments on rabbits indicate that the vaccinia virus modifies herpetic keratitis and repeated small pox vaccinations to prevent recurrences in obstinate cases have been tried from time-to-time for more than 40 years.
The ultimate hope is in a herpes vaccine itself. Soltz-Szots (1971) , in Vienna, reported that three-quarters of more than 500 patients treated ceased to have recurrences of herpes, including genital herpes.
So far there has been a lack of evaluation of the European (Diamant or Lupidon) and American (Lilly) inactivated vaccines and the possible mechansims of action have not yet been ascertained. However, the fear of carcinogenic risk of inactivated or live attenuated or mutant viruses-if the virus is indeed causally related to some human cancershas led to investigating the possibility of using DNA-free virus proteins (Nahmias et al., 1976) .
Needs for the future There is an obvious need for an effective and safe treatment of herpes that will eradicate the virus. One difficulty in assessing the results of any treatment of herpes is the wide range of natural behaviour of the disease. It is said that 50-75% of patients will have fewer recurrences of oral herpes virus infections after psychotherapy alone (Amstey, 1975) .
Prevention of venereal disease
The present state of venereal disease prophylaxis can be summed up in one, if long, sentence. Venereal disease can be prevented if before sexual intercourse the man applies a condom, the woman an antispetic cream, and if afterwards the man immediately passes water and annoints his genitalia with a prophylactic ointment while the woman has a prophylactic douche: both should then have a bath before spraying each other with an antiseptic lotion, and they should visit a physican to receive 2 4 megaunits of procaine penicillin by injection plus 10 g of probenecid by mouth-which should prevent gonorrhoea and syphilis-plus a 10-day course of oral tetracycline to prevent non-gonococcal urethritis and a one-or two-day course of metronidazole or nimorazole against trichomoniasis-even with such commendable caution the risk is not entirely removed of infection from the viruses of condylomata acuminata, molluscum contagiosum, or even that of hepatitis B: neither would it be beneficial for venerophobia!
